Association Between Serum Soluble CD30 and Serum Creatinine Before and After Renal Transplantation

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 2903-2905

  Lopez Hoyos M ^a   San Segundo, D ^a   Benito, M J ^a   Fernandez Fresnedo G ^a   Ruiz, J C ^a   Rodrigo, E ^a   Gomez Alamillo C ^a   Benito, A ^a   Arias, M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CREATININE;

ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, CD30; BIOLOGICAL MARKERS; CADAVER; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; TISSUE DONORS; TREATMENT OUTCOME;

EID: 55749108165     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.087     Document Type: Article

References (9)

1. Chan K.W., Hopke C.D., and Krams S.M. CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses. J Immunol 169 (2002) 1784
2. Pelzl S., Opelz G., and Weisel M. Soluble CD30 as a predictor of kidney graft outcome. Transplantation 73 (2002) 3
3. Sengul S., Keven K., and Gormez U. Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation. Transplantation 81 (2006) 1216
4. Vaidya S., Partlow D., and Barnes T. Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies. Clin Transplant 20 (2006) 461
5. Langan L.L., Park L.P., and Hughes T.L. Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. Am J Transplant 7 (2007) 847
6. Weimer R., Süsal C., and Yildiz S. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens. Am J Transplant 6 (2006) 1865
7. Altermann W., Schlaf G., and Rothhoff A. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection?. Nephrol Dial Transplant 22 (2007) 2795
8. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39 suppl 1 (2002) 1
9. Alcalde G., Merino J., and Sanz S. Circulating adhesion molecules during kidney allograft rejection. Transplantation 59 (1995) 1695